PURPOSE Corneal Crosslinking (CXL) strengthens the keratoconus cornea and prevents further disease progression. Modified crosslinking protocols and different riboflavin solutions have been proposed to optimize the procedure and improve treatment success. METHODS PubMed research of relevant publications and report of own experiences with different CXL protocols. RESULTS Accelerated CXL shows comparable efficiency with shorter surgery time and similar complication rates. Customized CXL provides improved results with faster epithelial healing. CXL in a hyperoxic environment seems to be a safe and effective transepithelial alternative with presumably less complications and fewer side effects. Thin corneas (<400 µm) can be treated...
Corneal cross-linking (CXL), introduced by Wollensak et al. in 2003, is a minimally invasive procedu...
ABSTRACT The induction of corneal collagen cross-linking by ultraviolet radiation (UV) over a subs...
<p></p><p>ABSTRACT The purpose of this review is to determine the indications and efficacy of the su...
Keratoconus is a corneal disorder in which the cornea becomes cone-shaped due to stromal thinning an...
The past two decades have witnessed an unprecedented evolution in the management of keratoconus that...
Riboflavin UV-A Corneal Crosslinking was developed in the 1990s to treat progressive keratoconus. It...
Riboflavin UV-A Corneal Crosslinking was developed in the 1990s to treat progressive keratoconus. It...
Riboflavin UV-A Corneal Crosslinking was developed in the 1990s to treat progressive keratoconus. It...
Riboflavin UV-A Corneal Crosslinking was developed in the 1990s to treat progressive keratoconus. It...
Corneal cross-linking (CXL) using riboflavin and ultraviolet A (UVA) light has become a useful treat...
The initial published clinical report on riboflavin/ultraviolet A corneal cross-linking (CXL) for tr...
Background: Today corneal crosslinking with ultraviolet-A photoactivation of riboflavin is an establ...
Background: Today corneal crosslinking with ultraviolet-A photoactivation of riboflavin is an establ...
Keratoconus is a condition characterized by biomechanical instability of the cornea, presenting in a...
Corneal cross-linking (CXL), introduced by Wollensak et al. in 2003, is a minimally invasive procedu...
Corneal cross-linking (CXL), introduced by Wollensak et al. in 2003, is a minimally invasive procedu...
ABSTRACT The induction of corneal collagen cross-linking by ultraviolet radiation (UV) over a subs...
<p></p><p>ABSTRACT The purpose of this review is to determine the indications and efficacy of the su...
Keratoconus is a corneal disorder in which the cornea becomes cone-shaped due to stromal thinning an...
The past two decades have witnessed an unprecedented evolution in the management of keratoconus that...
Riboflavin UV-A Corneal Crosslinking was developed in the 1990s to treat progressive keratoconus. It...
Riboflavin UV-A Corneal Crosslinking was developed in the 1990s to treat progressive keratoconus. It...
Riboflavin UV-A Corneal Crosslinking was developed in the 1990s to treat progressive keratoconus. It...
Riboflavin UV-A Corneal Crosslinking was developed in the 1990s to treat progressive keratoconus. It...
Corneal cross-linking (CXL) using riboflavin and ultraviolet A (UVA) light has become a useful treat...
The initial published clinical report on riboflavin/ultraviolet A corneal cross-linking (CXL) for tr...
Background: Today corneal crosslinking with ultraviolet-A photoactivation of riboflavin is an establ...
Background: Today corneal crosslinking with ultraviolet-A photoactivation of riboflavin is an establ...
Keratoconus is a condition characterized by biomechanical instability of the cornea, presenting in a...
Corneal cross-linking (CXL), introduced by Wollensak et al. in 2003, is a minimally invasive procedu...
Corneal cross-linking (CXL), introduced by Wollensak et al. in 2003, is a minimally invasive procedu...
ABSTRACT The induction of corneal collagen cross-linking by ultraviolet radiation (UV) over a subs...
<p></p><p>ABSTRACT The purpose of this review is to determine the indications and efficacy of the su...